Compare Stocks: WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$29.46 +7.5%	$32.10	$13.74 ▼ $65.30	$6.87B	2.4	26.21 million shs	8.47 million shs
HIMS Hims & Hers Health	$29.46 +7.5%	$32.10	$13.74 ▼ $65.30	$6.87B	2.4	26.21 million shs	8.47 million shs
LFMD LifeMD	$3.38 +3.2%	$4.19	$2.56 ▼ $7.32	$162.19M	2.02	1.09 million shs	222,134 shs
LLY Eli Lilly and Company	$1,266.34 +3.3%	$1,173.20	$685.15 ▼ $1,292.65	$1.19T	0.51	3.10 million shs	2.47 million shs
NVO Novo Nordisk A/S	$46.38 +1.5%	$47.51	$35.12 ▼ $64.16	$206.84B	0.76	17.84 million shs	9.27 million shs
TDOC Teladoc Health	$6.56 +1.3%	$8.13	$4.40 ▼ $9.89	$1.19B	2.12	5.47 million shs	1.50 million shs
WW WW International	$14.14 +1.8%	$15.94	$8.36 ▼ $38.38	$141.44M	1.3	290,268 shs	22,004 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	-3.77%	-11.33%	-16.62%	+18.93%	-39.26%
HIMS Hims & Hers Health	-3.77%	-11.33%	-16.62%	+18.93%	-39.26%
LFMD LifeMD	-1.51%	-3.25%	-21.20%	-23.24%	-49.77%
LLY Eli Lilly and Company	+3.60%	+1.17%	+4.17%	+20.77%	+75.58%
NVO Novo Nordisk A/S	+1.83%	-3.19%	-9.11%	+1.43%	-15.05%
TDOC Teladoc Health	-1.42%	-5.25%	-31.59%	-0.28%	-13.81%
WW WW International	+2.28%	-7.46%	-4.67%	+39.88%	-54.86%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$29.46 +7.5%	$32.10	$13.74 ▼ $65.30	$6.87B	2.4	26.21 million shs	8.47 million shs
HIMS Hims & Hers Health	$29.46 +7.5%	$32.10	$13.74 ▼ $65.30	$6.87B	2.4	26.21 million shs	8.47 million shs
LFMD LifeMD	$3.38 +3.2%	$4.19	$2.56 ▼ $7.32	$162.19M	2.02	1.09 million shs	222,134 shs
LLY Eli Lilly and Company	$1,266.34 +3.3%	$1,173.20	$685.15 ▼ $1,292.65	$1.19T	0.51	3.10 million shs	2.47 million shs
NVO Novo Nordisk A/S	$46.38 +1.5%	$47.51	$35.12 ▼ $64.16	$206.84B	0.76	17.84 million shs	9.27 million shs
TDOC Teladoc Health	$6.56 +1.3%	$8.13	$4.40 ▼ $9.89	$1.19B	2.12	5.47 million shs	1.50 million shs
WW WW International	$14.14 +1.8%	$15.94	$8.36 ▼ $38.38	$141.44M	1.3	290,268 shs	22,004 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	-3.77%	-11.33%	-16.62%	+18.93%	-39.26%
HIMS Hims & Hers Health	-3.77%	-11.33%	-16.62%	+18.93%	-39.26%
LFMD LifeMD	-1.51%	-3.25%	-21.20%	-23.24%	-49.77%
LLY Eli Lilly and Company	+3.60%	+1.17%	+4.17%	+20.77%	+75.58%
NVO Novo Nordisk A/S	+1.83%	-3.19%	-9.11%	+1.43%	-15.05%
TDOC Teladoc Health	-1.42%	-5.25%	-31.59%	-0.28%	-13.81%
WW WW International	+2.28%	-7.46%	-4.67%	+39.88%	-54.86%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HIMS Hims & Hers Health	2.19	Hold	$32.43	10.11% Upside
HIMS Hims & Hers Health	2.19	Hold	$32.43	10.11% Upside
LFMD LifeMD	2.70	Moderate Buy	$7.57	124.34% Upside
LLY Eli Lilly and Company	2.83	Moderate Buy	$1,292.18	2.04% Upside
NVO Novo Nordisk A/S	2.20	Hold	$64.94	40.01% Upside
TDOC Teladoc Health	2.25	Hold	$7.54	14.96% Upside
WW WW International	1.67	Reduce	N/A	N/A

Current Analyst Ratings Breakdown

Latest WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	LFMD LifeMD	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/12/2026	NVO Novo Nordisk A/S	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$47.00
8/12/2026	NVO Novo Nordisk A/S	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/11/2026	LLY Eli Lilly and Company	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B) ➝ Buy (B-)
8/11/2026	HIMS Hims & Hers Health	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $26.00
8/11/2026	HIMS Hims & Hers Health	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $26.00
8/11/2026	HIMS Hims & Hers Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $30.00
8/11/2026	HIMS Hims & Hers Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $30.00
8/11/2026	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$21.00 ➝ $28.00
8/11/2026	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$21.00 ➝ $28.00
8/11/2026	HIMS Hims & Hers Health	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$35.00 ➝ $33.00

(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HIMS Hims & Hers Health	$2.35B	2.93	$0.88 per share	33.64	$2.38 per share	12.38
HIMS Hims & Hers Health	$2.35B	2.93	$0.88 per share	33.64	$2.38 per share	12.38
LFMD LifeMD	$194.05M	0.84	N/A	N/A	$0.48 per share	7.03
LLY Eli Lilly and Company	$79.67B	14.96	$26.97 per share	46.95	$28.07 per share	45.11
NVO Novo Nordisk A/S	$46.80B	4.43	$4.74 per share	9.79	$6.58 per share	7.05
TDOC Teladoc Health	$2.53B	0.47	$1.73 per share	3.78	$7.81 per share	0.84
WW WW International	$710.64M	0.20	$11.98 per share	1.18	($9.62) per share	-1.47

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	58.91	N/A	-5.51%	-6.51%	-1.20%	11/2/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	58.91	N/A	-5.51%	-6.51%	-1.20%	11/2/2026 (Estimated)
LFMD LifeMD	$14.35M	-$0.05	N/A	48.21	N/A	0.10%	-168.23%	-31.27%	N/A
LLY Eli Lilly and Company	$20.64B	$29.80	42.51	27.61	1.39	33.53%	97.83%	23.23%	10/29/2026 (Estimated)
NVO Novo Nordisk A/S	$15.51B	$4.09	11.33	13.76	4.15	35.36%	61.20%	21.49%	11/4/2026 (Estimated)
TDOC Teladoc Health	-$200.32M	-$0.99	N/A	N/A	N/A	-7.13%	-12.15%	-5.83%	10/28/2026 (Estimated)
WW WW International	-$112.25M	-$10.13	N/A	N/A	N/A	-56.84%	N/A	-0.32%	11/5/2026 (Estimated)

Latest WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
8/5/2026	Q2 2026	LFMD LifeMD	-$0.1457	-$0.16	-$0.0143	-$0.16	$49.16 million	$47.28 million
8/5/2026	Q2 2026	LLY Eli Lilly and Company	$6.40	$8.38	+$1.98	$7.94	$20.82 billion	$22.97 billion
8/5/2026	Q2 2026	NVO Novo Nordisk A/S	$0.77	$0.96	+$0.19	$0.72	$10.89 billion	$11.98 billion
8/5/2026	Q2 2026	WW WW International	$0.48	$1.41	+$0.93	$1.41	$159.13 million	$162.32 million
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.2498	-$0.21	+$0.0398	-$0.21	$615.44 million	$606.93 million
6/30/2026	Q2 2026	NVO Novo Nordisk A/S	N/A	$0.9440	N/A	$0.72	N/A	$11.98 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LFMD LifeMD	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.92	0.55%	+15.18%	23.22%	11 Years
NVO Novo Nordisk A/S	$1.75	3.77%	+21.74%	42.79%	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A
WW WW International	N/A	N/A	N/A	N/A	N/A

Latest WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/22/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.59%	8/14/2026	8/14/2026	9/10/2026
8/5/2026	NVO Novo Nordisk A/S		$0.5786	2.58%	8/17/2026	8/17/2026	8/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HIMS Hims & Hers Health	4.21	0.93	0.87
HIMS Hims & Hers Health	4.21	0.93	0.87
LFMD LifeMD	N/A	0.90	0.84
LLY Eli Lilly and Company	1.41	1.35	1.00
NVO Novo Nordisk A/S	0.59	0.79	0.56
TDOC Teladoc Health	N/A	0.83	0.81
WW WW International	N/A	0.53	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HIMS Hims & Hers Health	63.52%
HIMS Hims & Hers Health	63.52%
LFMD LifeMD	35.52%
LLY Eli Lilly and Company	82.53%
NVO Novo Nordisk A/S	11.54%
TDOC Teladoc Health	76.82%
WW WW International	86.18%

Insider Ownership

Company	Insider Ownership
HIMS Hims & Hers Health	11.76%
HIMS Hims & Hers Health	11.76%
LFMD LifeMD	17.22%
LLY Eli Lilly and Company	0.14%
NVO Novo Nordisk A/S	0.07%
TDOC Teladoc Health	0.70%
WW WW International	0.39%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
LFMD LifeMD	230	48.20 million	39.90 million	Optionable
LLY Eli Lilly and Company	50,000	941.36 million	940.04 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
TDOC Teladoc Health	5,600	181.68 million	180.41 million	Optionable
WW WW International	7,700	10.00 million	73.38 million	Optionable

WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Headlines

Recent News About These Companies

Wall Street Zen Upgrades WW International (NASDAQ:WW) to Hold

August 8, 2026 | americanbankingnews.com

WW International (NASDAQ:WW) Upgraded at Wall Street Zen

August 8, 2026 | marketbeat.com

What Prediction Markets Say About 3 Struggling Brands Fighting to Survive

August 7, 2026 | 247wallst.com

WW reaffirms $620M-$635M 2026 revenue outlook while targeting 25%-30% clinical mix

August 6, 2026 | seekingalpha.com

WW International, Inc. (WW) Q2 2026 Earnings Call Transcript

August 6, 2026 | seekingalpha.com

WW International Q2 Earnings Call Highlights

August 6, 2026 | marketbeat.com

WW International (NASDAQ:WW) Posts Earnings Results, Beats Estimates By $0.93 EPS

August 5, 2026 | marketbeat.com

Weight Watchers Announces Second Quarter 2026 Results

August 5, 2026 | globenewswire.com

WW International (WW) Projected to Post Quarterly Earnings on Wednesday

July 29, 2026 | marketbeat.com

Cooper Creek Partners Management LLC Raises Stock Holdings in WW International, Inc. $WW

July 26, 2026 | marketbeat.com

Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call

July 23, 2026 | globenewswire.com

Walmart Super-Sizes Wellness Vision with Weight Watchers International Deal

July 9, 2026 | tipranks.com

WW International Inc.: Sam's Club and Weight Watchers Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members

July 9, 2026 | finanznachrichten.de

Sam's Club® and Weight Watchers® Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members

July 9, 2026 | globenewswire.com

WW International Inc.: Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community

July 8, 2026 | finanznachrichten.de

Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community

July 8, 2026 | globenewswire.com

WW International Inc.: Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

June 30, 2026 | finanznachrichten.de

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

June 30, 2026 | globenewswire.com

WW International Inc (NASDAQ: WW) - Share Price and Research

June 27, 2026 | intelligentinvestor.com.auI

Weight Watchers to Support the American Heart Association's Healthy Living BEYOND Weight Study

June 22, 2026 | globenewswire.com

WW International Inc.: Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

June 16, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Company Descriptions

Hims & Hers Health NYSE:HIMS

$29.46 +2.07 (+7.54%)

As of 12:51 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health NYSE:HIMS

$29.46 +2.07 (+7.54%)

As of 12:51 PM Eastern

LifeMD NASDAQ:LFMD

$3.38 +0.11 (+3.21%)

As of 12:51 PM Eastern

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Eli Lilly and Company NYSE:LLY

$1,266.34 +40.61 (+3.31%)

As of 12:51 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S NYSE:NVO

$46.38 +0.67 (+1.46%)

As of 12:51 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teladoc Health NYSE:TDOC

$6.56 +0.09 (+1.31%)

As of 12:51 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

WW International NASDAQ:WW

$14.14 +0.25 (+1.81%)

As of 12:50 PM Eastern

WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other people on weight health journeys. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Earnings

Compare Dividends

Latest WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WW, TDOC, HIMS, LLY, NVO, HIMS, and LFMD Company Descriptions

Hims & Hers Health NYSE:HIMS

Hims & Hers Health NYSE:HIMS

LifeMD NASDAQ:LFMD

Eli Lilly and Company NYSE:LLY

Novo Nordisk A/S NYSE:NVO

Teladoc Health NYSE:TDOC

WW International NASDAQ:WW

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools